2021
DOI: 10.3390/ph14010069
|View full text |Cite
|
Sign up to set email alerts
|

Activatable Nanoparticles: Recent Advances in Redox-Sensitive Magnetic Resonance Contrast Agent Candidates Capable of Detecting Inflammation

Abstract: The emergence of activatable magnetic resonance (MR) contrast agents has prompted significant interest in the detection of functional markers of diseases, resulting in the creation of a plethora of nanoprobes capable of detecting these biomarkers. These markers are commonly dysregulated in several chronic diseases, specifically select cancers and inflammatory diseases. Recently, the development of redox-sensitive nanoparticle-based contrast agents has gained momentum given advances in medicine linking several … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 59 publications
0
2
0
Order By: Relevance
“…In recent decades, several kinds of MRI contrast agents that were responsive to reductive GSH or ROS have been developed. However, most of them employed irreversible reaction with the specific ROS or GSH, thus giving irreversible interaction between the probes and analytes. Meanwhile, most of them failed to detect oxidant and antioxidant levels simultaneously.…”
Section: Discussionmentioning
confidence: 99%
“…In recent decades, several kinds of MRI contrast agents that were responsive to reductive GSH or ROS have been developed. However, most of them employed irreversible reaction with the specific ROS or GSH, thus giving irreversible interaction between the probes and analytes. Meanwhile, most of them failed to detect oxidant and antioxidant levels simultaneously.…”
Section: Discussionmentioning
confidence: 99%
“…IPC-SPIOs are comprised of superparamagnetic iron oxide nanoparticles (SPIOs) coated in poly(ethylene glycol) (PEG), which are complexed through hydrogen bonding with poly(gallol). 4–6 One of the main challenges in nanomedicine is selectively and specifically delivering nanoparticles to desired sites, which limits the translation of innovations from laboratory to clinical settings. 7–12 An effective targeted nanoparticle avoids off-target effects while improving specific targeting to the disease location.…”
Section: Introductionmentioning
confidence: 99%